+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Diabetic Retinopathy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • ID: 5401365
  • Report
  • August 2021
  • Region: Global
  • 142 Pages
  • IMARC Group

FEATURED COMPANIES

  • Alimera Sciences
  • Allergan PLC
  • Ampio Pharmaceuticals
  • Bayer Healthcare
  • BCN Peptides
  • Genentech
The global diabetic retinopathy market reached a value of US$ 7.64 Billion in 2020. Looking forward, the publisher expects the market to grow at a CAGR of 5.6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Diabetic retinopathy (DR) refers to the damage caused to the blood vessels in the retina by diabetes mellitus. This ailment is of two kinds, namely non-proliferative DR and proliferative or advanced DR. It is caused by fluctuations in the blood glucose levels resulting in an abnormal growth in the light-sensitive tissues present in the eye. The symptoms of DR include the visibility of dark spots or floating strings in the vision field, blurred or fluctuating vision, impaired color vision or loss of vision. It can be diagnosed through tests, such as fluorescein angiography and optical coherence tomography, and the treatment involves the use of intraocular steroid injection, laser treatment and vitrectomy.

The increasing prevalence of diabetes, along with the growing geriatric population across the globe, represent as the key factors driving the growth of the market. Furthermore, the rising incidence of blindness caused by DR is also providing a boost to the market growth. There is an increasing awareness among the masses regarding the available treatment alternatives and the benefits of early detection of DR. This has resulted in the widespread adoption of technologically advanced procedures and equipment, such as the improved ophthalmic diagnostic and surgical instruments. These procedures and equipment enable early detection and efficient treatment of the ailment with higher precision and minimal discomfort to the patient. Other factors, including the increasing healthcare expenditures, the implementation of favorable government policies to make advanced healthcare services available to the masses and extensive research and development (R&D) activities, are projected to drive the market further.

Breakup by Type:

  • Proliferative Diabetic Retinopathy
  • Non-proliferative Retinopathy

Breakup by Treatment Type:

  • Anti VEGF Drugs
  • Steroid Implants
  • Laser Surgeries
  • Vitrectomy

Breakup by End-User:

  • Hospitals and Pharmacies
  • Eye Clinics
  • Ambulatory Surgical Centres (ASCs)
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Alimera Sciences, Allergan PLC, Ampio Pharmaceuticals, Bayer Healthcare, BCN Peptides, Genentech, Kowa Group, Novartis AG, Regeneron Pharmaceuticals Inc., Sirnaomics Inc., etc.

Key Questions Answered in This Report:

  • How has the global diabetic retinopathy market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global diabetic retinopathy market?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global diabetic retinopathy market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alimera Sciences
  • Allergan PLC
  • Ampio Pharmaceuticals
  • Bayer Healthcare
  • BCN Peptides
  • Genentech
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Diabetic Retinopathy Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type
6.1 Proliferative Diabetic Retinopathy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Non-proliferative Retinopathy
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Treatment Type
7.1 Anti VEGF Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Steroid Implants
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Laser Surgeries
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Vitrectomy
7.4.1 Market Trends
7.4.2 Market Forecast

8 Market Breakup by End-User
8.1 Hospitals and Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Eye Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ambulatory Surgical Centers (ASCs)
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Alimera Sciences
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.2 Allergan Plc
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Ampio Pharmaceuticals
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Bayer Healthcare
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 BCN Peptides
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 Genentech
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 SWOT Analysis
13.3.7 Kowa Group
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 Novartis AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9 Regeneron Pharmaceuticals Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Sirnaomics Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio

List of Figures
Figure 1: Global: Diabetic Retinopathy Market: Major Drivers and Challenges
Figure 2: Global: Diabetic Retinopathy Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Diabetic Retinopathy Market: Breakup by Type (in %), 2020
Figure 4: Global: Diabetic Retinopathy Market: Breakup by Treatment Type (in %), 2020
Figure 5: Global: Diabetic Retinopathy Market: Breakup by End-User (in %), 2020
Figure 6: Global: Diabetic Retinopathy Market: Breakup by Region (in %), 2020
Figure 7: Global: Diabetic Retinopathy Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 8: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Diabetic Retinopathy (Steroid Implants) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Diabetic Retinopathy (Steroid Implants) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Diabetic Retinopathy (Laser Surgeries) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Diabetic Retinopathy (Laser Surgeries) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Diabetic Retinopathy (Vitrectomy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Diabetic Retinopathy (Vitrectomy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Diabetic Retinopathy (Eye Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Diabetic Retinopathy (Eye Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Diabetic Retinopathy (Ambulatory Surgical Centers- ASCs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Diabetic Retinopathy (Ambulatory Surgical Centers-ASCs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Diabetic Retinopathy (Others) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Diabetic Retinopathy (Others) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: North America: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: North America: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: United States: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: United States: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Canada: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Canada: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Asia Pacific: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Asia Pacific: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: China: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: China: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Japan: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Japan: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: India: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: India: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: South Korea: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: South Korea: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Australia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Australia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Indonesia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Indonesia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Europe: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Europe: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Germany: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Germany: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: France: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: France: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: United Kingdom: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: United Kingdom: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Italy: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Italy: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Spain: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Spain: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Russia: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Russia: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Latin America: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Latin America: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Brazil: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Brazil: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Mexico: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Mexico: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Others: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Middle East and Africa: Diabetic Retinopathy Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Middle East and Africa: Diabetic Retinopathy Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Global: Diabetic Retinopathy Industry: SWOT Analysis
Figure 77: Global: Diabetic Retinopathy Industry: Value Chain Analysis
Figure 78: Global: Diabetic Retinopathy Industry: Porter’s Five Forces Analysis

List of Tables
Table 1: Global: Diabetic Retinopathy Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Diabetic Retinopathy Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Diabetic Retinopathy Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
Table 4: Global: Diabetic Retinopathy Market Forecast: Breakup by End-User (in Million US$), 2021-2026
Table 5: Global: Diabetic Retinopathy Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Diabetic Retinopathy Market: Competitive Structure
Table 7: Global: Diabetic Retinopathy Market: Key Players
Note: Product cover images may vary from those shown
  • Alimera Sciences
  • Allergan PLC
  • Ampio Pharmaceuticals
  • Bayer Healthcare
  • BCN Peptides
  • Genentech
  • Kowa Group
  • Novartis AG
  • Regeneron Pharmaceuticals Inc.
  • Sirnaomics Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...